[{"address1": "Clarence Thomas Building", "address2": "P.O. Box 4649 Road Town", "city": "Tortola", "zip": "VG1110", "country": "British Virgin Islands", "phone": "302 219 5556", "website": "https://www.portagebiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-3, a polylactide-co-glycolide, which is in phase 1 to treat NY-ESO-1 positive tumors; PORT-6, a highly selective A2A receptor antagonist, which is in phase 1a for the treatment of solid tumors; PORT-8, a dual inhibitor of adenosine receptors 2A and 2B, which is in preclinical trial to treat solid tumors; PORT-9, an A2B antagonist, which is in pre-clinical stage program to treat colorectal and gastrointestinal cancers; PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; PORT-5, a VLP-STING to treat of solid tumors and is in preclinical trials; and PORT-7, a potent and selective antagonist of the adenosine A2B receptor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Adam  Melero", "title": "Controller", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Molloy", "title": "Chief Executive Officer of Cyncado Therapeutics Inc.", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.96, "open": 7.6, "dayLow": 6.8005, "dayHigh": 9.43, "regularMarketPreviousClose": 6.96, "regularMarketOpen": 7.6, "regularMarketDayLow": 6.8005, "regularMarketDayHigh": 9.43, "payoutRatio": 0.0, "beta": 0.637, "forwardPE": -13.096154, "volume": 371668, "regularMarketVolume": 371668, "averageVolume": 118306, "averageVolume10days": 156690, "averageDailyVolume10Day": 156690, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 15517402, "fiftyTwoWeekLow": 2.95, "fiftyTwoWeekHigh": 23.01, "fiftyDayAverage": 6.87217, "twoHundredDayAverage": 6.2301965, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 10044490, "profitMargins": 0.0, "floatShares": 829851, "sharesOutstanding": 2278620, "sharesShort": 36165, "sharesShortPriorMonth": 51030, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0159, "heldPercentInsiders": 0.60566, "heldPercentInstitutions": 0.04168, "shortRatio": 0.88, "shortPercentOfFloat": 0.0416, "impliedSharesOutstanding": 2278620, "bookValue": -0.074, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -6767000, "trailingEps": -5.72, "forwardEps": -0.52, "lastSplitFactor": "1:20", "lastSplitDate": 1723680000, "enterpriseToEbitda": -1.36, "52WeekChange": 0.49489796, "SandP52WeekChange": 0.16885936, "quoteType": "EQUITY", "currentPrice": 6.81, "recommendationKey": "none", "totalCash": 1670000, "totalCashPerShare": 0.733, "ebitda": -7383000, "totalDebt": 0, "quickRatio": 1.529, "currentRatio": 2.023, "returnOnAssets": -0.92688006, "returnOnEquity": -5.41807, "freeCashflow": -3330125, "operatingCashflow": -5462000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PRTG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChange": -0.15, "regularMarketDayRange": "6.8005 - 9.43", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 118306, "fiftyTwoWeekLowChange": 3.86, "fiftyTwoWeekLowChangePercent": 1.3084745, "fiftyTwoWeekRange": "2.95 - 23.01", "fiftyTwoWeekHighChange": -16.2, "fiftyTwoWeekHighChangePercent": -0.7040417, "fiftyTwoWeekChangePercent": 49.489796, "dividendDate": 1591228800, "earningsTimestampStart": 1757966400, "earningsTimestampEnd": 1757966400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.72, "epsForward": -0.52, "fiftyDayAverageChange": -0.06217003, "fiftyDayAverageChangePercent": -0.009046637, "twoHundredDayAverageChange": 0.57980347, "twoHundredDayAverageChangePercent": 0.09306343, "priceToBook": -92.02702, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-25", "shortName": "Portage Biotech Inc.", "longName": "Portage Biotech Inc.", "regularMarketPrice": 6.81, "regularMarketChangePercent": -2.15517, "marketState": "CLOSED", "firstTradeDateMilliseconds": 916929000000, "exchange": "NCM", "messageBoardId": "finmb_233586353", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "cryptoTradeable": false, "hasPrePostMarketData": true, "corporateActions": [], "regularMarketTime": 1756929600, "displayName": "Portage Biotech", "trailingPegRatio": null, "__fetch_time": "2025-09-13"}]